This is Why Teva Pharmaceutical Industries’ Stock is Still Falling
After a disappointing second-quarter earnings report, along with a lowered guidance on Thursday, August 3rd, pharmaceutical company Teva Pharmaceutical Industries (NYSE:$TEVA) saw its stock plummet. On Friday, August 4th, Teva’s stock has continued to fall. ... [Read]
Pfizer Inc. Confirms FDA Approval of XELJANZ Today
On August 3, Pfizer Inc. (NYSE:$PFE) disclosed that the United States FDA’s Arthritis Advisory Committee (AAC) voted 10 to 1 to recommend approval of the proposed dose of tofacitinib. This will be used to treat ... [Read]
Teva Pharmaceutical Posts Second-Quarter Earnings; Shares Drop More Than 18%
On Thursday, in morning trade, Teva Pharmaceutical (TLV:$TEVA) shares dropped more than 18%. It all started after the Petah Tikva, Israel-based company posted lower-than-expected second-quarter earnings. The multinational pharmaceutical company missed estimates for earnings per share ... [Read]
Pfizer Stock Rises Slightly Thanks to BMO Upgrade
Pharmaceutical company Pfizer’s (NYSE:$PFE) stock went up by 0.46% by market close on Wednesday, August 2. The rise was mainly due to BMO (TSE:$BMO) Capital Markets upgrading the stock from “Market Perform” to “Perform”. BMO ... [Read]
This is Why Pfizer’s Quarterly Revenue Missed Wall Street Expectations
Before the market opened on Tuesday, Pfizer Inc. (NYSE:$PFE) reported its quarterly revenue. Unfortunately, the revenue missed Wall Street estimates. Many speculate the miss in quarterly revenue was caused by a lower demand for Enbrel – ... [Read]
Merck & Company Reported a Quarter Two Earnings Increase
On Friday, July 28, Merck & Company (NYSE:$MRK) announced that its Q2 earnings increased as the drugmaker had blockbuster growth for its cancer drug Keytruda. Based on the Q2 earnings report, Merck’s new products helped ... [Read]
Bristol-Myers Reported Q2 Profit Match and Revenue Beat, But Shares Still Fell 6.2%
On July 27, Bristol-Myers Squibb Co. (NYSE:$BMY) reported a Q2 profit match and revenue beat. However, shares fell 6.2% in pre-market trade after AstraZeneca’s late-stage clinical trial failed. Why did this affect the company’s stock? ... [Read]
Tetraphase Pharmaceuticals Saw an Increase in Shares Today, Here’s Why!
Tetraphase Pharmaceuticals (NASDAQ:$TTPH) saw an increase in shares today. And when I say increase, I mean a whopping 27% increase. It all started after the Watertown, Massachusetts-based company disclosed positive top-line results for a phase ... [Read]
Eli Lilly Releases Q2 Earnings Report, Beats Profit and Sales Expectations
On July 25, Eli Lilly & Company (NYSE:$LLY) reported a Q2 net profit that increased to $1.01 billion (95 cents a share) from $747.7 million (71 cents a share), in the same time frame in ... [Read]
The Latest Creation From the Cannabis Sector is a Cannabis-Infused Keurig Cup Line
Now that support for cannabis has grown to a majority, the question of national legalization is not so much a matter of “if” but “when.” Until this point, the cannabis sector in California has been ... [Read]